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Abstract
Background: Recent reports indicate the existence of breast cancer cells expressing very high
levels of the Arylhydrocarbon receptor (AhR), a ubiquitous intracellular receptor best known for
mediating toxic action of dioxin and related pollutants. Positive correlation between the degree of
AhR overexpression and states of increasing transformation of mammary epithelial cells appears to
occur in the absence of any exogenous AhR ligands. These observations have raised many questions
such as why and how AhR is overexpressed in breast cancer and its physiological roles in the
progression to advanced carcinogenic transformation. To address those questions, we
hypothesized that AhR overexpression occurs in cells experiencing deficiencies in normally
required estrogen receptor (ER) signaling, and the basic role of AhR in such cases is to guide the
affected cells to develop orchestrated cellular changes aimed at substituting the normal functions
of ER. At the same time, the AhR serves as the mediator of the cell survival program in the absence
of ER signaling.
Methods: We subjected two lines of Michigan Cancer Foundation (MCF) mammary epithelial cells
to 3 different types ER interacting agents for a number of passages and followed the changes in the
expression of AhR mRNA. The resulting sublines were analyzed for phenotypical changes and
unique molecular characteristics.
Results: MCF10AT1 cells continuously exposed to 17-beta-estradiol (E2) developed sub-lines that
show AhR overexpression with the characteristic phenotype of increased proliferation, and distinct
resistance to apoptosis. When these chemically selected cell lines were treated with a specific AhR
antagonist, 3-methoxy-4-nitroflavone (MNF), both of the above abnormal cellular characteristics
disappeared, indicating the pivotal role of AhR in expressing those cellular phenotypes. The most
prominent molecular characteristics of these AhR overexpressing MCF cells were found to be
overexpression of ErbB2 and COX-2. Furthermore, we could demonstrate that suppression of
AhR functions through anti-AhR siRNA or MNF causes the recovery of ERalpha functions.
Conclusion: One of the main causes for AhR overexpression in these MCF breast cancer cells
appears to be the loss of ERalpha functions. This phenomenon is likely to be based on the mutually
antagonistic relationship between ER and AhR.
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The arylhydrocarbon receptor (AhR), a ubiquitous basic
Helix-Loop-Helix (bHLH) receptor expressed in various
tissues in vertebrate species, is best known for its role in
mediating the toxic actions of dioxin. On the molecular
level it is known that: (a) dioxin binds to AhR, which
exists in cytosol as a complex with a number of chaperone
proteins, (b) the resulting dioxin-bound AhR migrates
into nucleus where it forms a dimer with ARNT, another
bHLH protein, (c) it is this dimer, which binds to the
dioxin response element (DRE) on the promoters of the
dioxin target genes, and (d) thereby causes induction of a
number of detoxification enzymes. Tremendous efforts
have been made in the past 25 years in elucidating the
intricate molecular mechanisms through which this
receptor accomplishes its tasks of inducing a number of
detoxification enzymes and related proteins, particularly
in the liver upon biding of dioxin and related environ-
mental pollutants [1-3].
Recently, a surprising discovery has been made by David
H. Sherr and his colleagues at Boston University that the
AhR is overexpressed in DMBA-induced tumors in vivo in
rats [4] as well as in mice [5]. Furthermore, the same
group discovered that several in vitro cultured mouse as
well as human breast cancer cell lines show high levels of
expression of AhR [6]. In all these cases, the cells studied
show the typical characteristics of advanced transforma-
tion. These scientists consider that in these cases, AhR
itself must be playing the important tumor promoting
roles in the development of mammary tumors even with-
out the aid of its exogenous ligand [7]. Indeed artificial
expression of AhRR, a specific "negative regulator" protein
of AhR profoundly suppresses the growth of human
mammary tumor cells as well as that of primary cultures
of human thereby supporting the above notion that the
presence of functionally-active AhR itself is the primary
engine for these cells to maintain aggressive proliferation
[8-10]. These landmark observations naturally have raised
a new set of important toxicological questions; for
instance, what the main cause for overexpression of AhR,
how the overexpressed AhR contributes to those cellular
changes even in the absence of its ligands, and how it con-
tributes to malignant progression of those cells? These
questions have prompted us to undertake the current
investigation.
It is important to point out first that little is known about
the natural physiological roles of AhR, which is defined as
its active functions occurring in cells without the aid of
exogenously introduced ligands, despite the colossal
amounts of information available on the action of dioxins
to activate AhR. Most of the clues for the possible physio-
logical roles of AhR come from several studies on AhR-
null (knockout) mice. It was originally reported from
Chris Bradfield's group [11] that neonates of AhR-null
mice develop liver abnormalities (e.g. in terms of reduced
weight, and transient microvesicular fatty metamorpho-
sis). Gonzalez et al. [12] have reported that their strain of
AhR-null mice also show liver abnormalities which are
accompanied with increased rates of apoptosis and
increased production of TGF-β, probably due to excess
retinoic acid accumulation. In the case of developing
mammary epithelial tissues, it was reported by Hushka et
al [13] that AhR-null mice show 50% reduction in the for-
mation of terminal end buds (TEBs) in their mammary
glands during estrous-stimulated growth and branding of
ductal structures in the process of forming the lobule.
Together, these observations implicate that there is a nat-
ural role of the AhR in coordinating animal development,
cell growth, signaling of hormone receptors, and
cytokine/growth factor production.
While the above observations on AhR-null mice have
been helpful in demonstrating some of the consequences
of AhR absence particularly during the development of
animals, they by themselves do not indicate consequences
of AhR overexpression in those mammary tumor cells. In
this regard, one concrete example of the direct conse-
quence of AhR overexpression has been provided by
Andersson et al.[14], who produced a transgenic mouse
strain that expresses a constitutively active AhR, and
found that those mice developed distinct stomach
tumors. This finding demonstrates that artificial overex-
pression of AhR is directly related to one type of tumor
formation.
Based on the above observations, all implicating possible
contribution of AhR on carcinogenesis, we have set our
major objectives of this study as follows: first to identify at
least a major cause for mammary epithelial cells to over-
express AhR, and second, to determine at least one essen-
tial role of AhR in those cells in expressing the phenotypic
sign of advanced state of cell transformation.
Methods
Materials
Human recombinant EGF, serum and other media sup-
plies were obtained from Gibco BRL (Gaithersburg, MD).
[y-32P]ATP (4000 Ci/mmol) was purchased from ICN
(Costa Mesa, CA). TCDD (>99.9% purity) was originally
obtained from Dow Chemicals Co. 17-β-Estradiol (E2),
and 4-OH-Tamoxifen (Tam) were obtained from Sigma-
Aldrich Chemical Co. (St. Louis, MO). β-hexachlorocy-
clohexane (β-HCH) was purchased from Chem Service
(Westchester, PA), Parthenolide, Resveratrol, and AG879
were obtained from Calibiochem (San Diego, CA).
3xERE-TATA-luciferase cDNA was a kind gift from D.
McDonnell (Duke University Medical Center, Durham,
NC. 3'-Methoxy-4'-nitroflavone (MNF) was a kind giftPage 2 of 15
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Environmental Research, Germany)
Cell culture conditions for MCF10AT1 cell lines
MCF10AT1 cells were obtained from the Michigan Cancer
Foundation, maintained in phenol red free Dulbecco's
modified Eagle's medium with F12 nutrient mixtures
(DMEM/F12; Gibco, BRL) and supplemented with 2.5%
heat treated equine serum, 20 ng/mL EGF, 100 U/mL pen-
icillin, and 100 μg/mL streptomycin at 37°C under 5%
CO2 conditions. Cell culturing/selection was accom-
plished by seeding 1,000,000 cells (approximately 2.5%
of a near confluent plate) into a 100 mm plate containing
the above media and chemicals. In addition, selection
chemicals (E2, 1 nM; Tam 10 nM; and β-HCH 1 μM final
concentration) were added to the plates. Media and chem-
icals were refreshed twice a week and the plates were
reseeded when plates reached 80–90 percent confluency
(on average every 10–14 days). For the quantification of
our long-term studies, each reseeding event constituted
one passage.
Proliferation test assay for MCF10AT1 cell lines
After 20 passages, cells were reseeded for cell proliferation
assays. Cells were trypsinized from a starter plate and
seeded at a concentration of approximately 50,000 cells
per well in a 12 well plate. After 24 hours, the media was
changed and one set of wells were trypsinized and
counted with a hemocytometer to determine starting con-
centration of cells. It must be noted that none of the selec-
tion chemicals (i.e. E2, Tam or β-HCH were added to the
cell culture media used during this assay). After an addi-
tional 48 hours, cells were trypsinized and counted with a
hemocytometer. Trypan blue exclusion (0.08% dye) was
used to determine viable cells (normally >96% of total
cells).
mRNA analysis of gene expression for MCF10AT1 cell lines
Cells that have been selected for 20 passages in our test
chemicals were trypsinized and reseeded (500,000) into
60 mm dishes in our culture media. Note: no additional
selection chemicals (i.e. E2, Tamoxifen, β-HCH) were
added to the media during this analysis. After 24–48
hours, the media was refreshed with serum free media. For
serum-free ("starved") media studies – following an addi-
tional 24 hours, test chemicals were added for an addi-
tional 3 hours and the mRNA was extracted from the cells.
For "fresh" serum containing studies- following 21 hours
from the last serum free media change, the cells were
refreshed selection media described above, and chemicals
were added 3 hours latter. The mRNA from these samples
were then extracted 3 hours after chemical addition. For
all cases mRNA extraction were completed using the Qia-
gen (Valencia, CA) RNAeasy kit. cDNA was prepared from
the extracted mRNA using the Omniscript Reverse Tran-
scriptase Kit (Qiagen) and analyzed by real-time PCR on
a Roche lightcycler.
Electrophoretic Mobility Shift Assays (EMSA)
Nuclear extracts were isolated from MCF10AT1 cells as
described by to Dennler et al [15]. In brief, MCF10AT1
cells were washed and harvested in Dulbecco's PBS con-
taining 1 mM phenylmethylsulfonyl fluoride (PMSF) and
0.05 μg/μl aprotinin. After centrifugation the cell pellets
were gently resuspended in 1 ml of hypotonic buffer (20
mM HEPES, 20 mM NaF, 1 mM Na3VO4, 1 mM Na4P2O7,
1 mM EDTA, 1 mM EGTA, 0.5 mM PMSF, 0.13 μM oka-
daic acid, 1 mM dithiolthreitol, pH 7.9, and 1 μg/ml each
leupeptin, aprotinin, and pepstatin). The cells were
allowed to swell on ice for 15 min and then homogenized
by 25 strokes of a Dounce homogenizer. After centrifuga-
tion for 1 min at 16,000 g, nuclear pellets were resus-
pended in 300 μl of ice-cold high salt buffer (hypotonic
buffer with 420 mM NaCl and 20% glycerol). The samples
were passed through a 21-gauge needle and stirred for 30
min at 4°C. The nuclear lysates were microcentrifuged at
16,000 g for 20 min, aliquoted, and stored at -70°C. Pro-
tein concentrations were determined by the method of
Bradford [16]. For EMSA, a double-stranded oligonucle-
otide corresponding to the DRE binding site or end-
labeled using [y-32P]ATP (Amersham Life Sciences) and
T4 polynucleotide kinase (Promega, Madison, WI)
according to the standard methods. DNA-protein-binding
reactions were carried out in a total volume of 20 μl con-
taining 15 μg of nuclear protein, 40,000 cpm of DNA oli-
gonucleotide, 25 mM Tris buffer, pH 7.5, 50 mM NaCl, 1
mM MgCl2, 1 mM EDTA, 0.5 mM dithiolthreitol, 5% glyc-
erol, and 1 μg of poly (dI-dC). Supershift analysis was per-
formed by adding 2 μg of monoclonal ARNT, polyclonal
RelB (Active Motif), or polyclonal AhR (Novus Biologi-
cals) antibodies to the reaction mixtures. Competition
experiments were performed in the presence of a 100-fold
molar excess of unlabeled DNA fragments. The samples
were incubated at room temperature for 20 min. Protein-
DNA complexes were resolved on a 5% non-denaturating
polyacrylamide gel and visualized by exposure of the
dehydrated gels to x-ray films. In all cases each EMSA test
was repeated more than two times to ascertain the repro-
ducibility of the overall pattern of nuclear protein binding
to the labeled oligonucleotides.
Antibodies and Western blotting
A polyclonal anti-human AhR (SC-5579), a polyclonal
antibody against human ACTIN (SC-1616), a horseradish
peroxidase conjugated secondary antibody, and pre-
stained standard markers (SC-2361) were obtained from
Santa Cruz Biotechnology (Santa Cruz, CA). Whole cell
lysates (30 μg) were separated on a 10% SDS-polyacryla-
mide gel and blotted onto a PVDF membrane (Immuno-
Blot, Bio-Rad, Hercules, CA). The antigen-antibody com-Page 3 of 15
(page number not for citation purposes)
BMC Cancer 2009, 9:234 http://www.biomedcentral.com/1471-2407/9/234plexes were visualized using the chemiluminescence sub-
strate SuperSignal®, West Pico (Pierce, Rockford, IL) as
recommended by the manufacturer. For quantitative anal-
ysis, respective bands were quantified using a ChemiIm-
ager™ 4400 (Alpha Innotech Corporation, San Leandro,
CA).
ERE-Luciferase experiments
For transient transfection experiments, cells were plated in
6-well culture plates (5 × 104/well). After 24 hrs, cells were
washed once with PBS, and 1.6 ml of fresh serum/phenol
red free growth medium was added before transfection
complexes were applied drop by drop to the cells. Cells
were transiently transfected for 16 hrs by using 10 μl per
well Effectene (Qiagen, Valencia, CA) with 0.5 μg per well
of respective luciferase reporter constructs of the 3 xERE-
TATA promoter according to the manufacturer's instruc-
tions. The serum and phenol-red free media was then
refreshed. After an additional 24 h incubation period, the
cells were washed twice with PBS and lysed with 300 μl of
passive lysis buffer. Luciferase activities were measured
with the Luciferase Reporter Assay System (Promega,
Madison, MI) using a luminometer (Berthold Lumat LB
9501/16, Pittsburgh, PA). Relative light units were nor-
malized to protein concentration, using a Bradford dye
assay (Bio-Rad). Experiments were repeated three times
and three wells of cells were analyzed per experiment.
Apoptosis Detection by Annexin V Staining
Cells were seeded at 1 × 105 cells in 60 mm culture dishes
in 2 ml medium after 24 hrs media was refreshed. After 21
hrs, cells were treated with various inhibitors and incu-
bated for and additional 3 hrs. Apoptosis was induced by
UV light (100 μJ/cm2) for 100 seconds and incubated at
37°C for 4 hrs. All media except for 200 μl was removed
from each plate. Afterwards, 2 μl CaCl2(20 mM), 2 μl
annexin V-fluorescein isothiocyanate (50 μg/ml, Sigma)
and 2 μl of propidium iodide (PI) solution (50 μg/ml)
were added directly to each plate. The cells were gently
mixed and incubated for 10 minutes at room temperature
in the dark. Apoptotic cells were counted directly by using
the fluorescence microscope (Leitz, Wetzlar, Germany). In
each experiment, ten representative fields were counted
for apoptosis assay. Both annexin V-positive and annexin
V-PI-double-positive cells were considered to be apop-
totic.
Statistical Analysis
All quantitative experiments were repeated a minimum of
three times and results are expressed as means ± standard
deviations. Data were evaluated statistically by one-way
ANOVA followed by Student's t test at the significant level
of P < 0.05.
Results
Genesis of AhR over-expressing MCF cells and their 
characterization
To address the question on the possible cause(s) of AhR
overexpression in mammary epithelial cells, we began this
project by exposing MCF10AT1 cells to three estrogen
receptor interacting chemicals, 1 nM E2, 10 nM 4-hydroxy-
tamoxifen, or 1 μM β-hexachlorohexane (β-HCH), an
estrogenic pesticide, throughout a number of passages
under our standard culture conditions using "selection
medium" which was phenol red-free and contained heat-
inactivated serum (2.5%) [17]. After 20 passages, those
selected cells have exhibited distinct signs of increased
proliferation, when tested in "selection medium" (Figure
1). To gain insight into the main cause for such pheno-
typic changes in each of selected cell line, we have tested
the effectiveness of two well known chemical inhibitors,
AG879, a specific inhibitor for ErbB2 associated tyrosine
kinase, and 3-methoxy-4-nitroflavone (MNF), a specific
antagonist to the Ah receptor (AhR) on those cells (Table
1). It was found that MNF was particularly effective in sup-
pressing the rate of proliferation of E2 selected lines, while
AG879 was more effective in this regard on those selected
by 4-hydroxy-tamoxifen (Tam) or by β-HCH (Table 1),
suggesting perhaps that AhR plays an important role in
inducing increased proliferation of the E2-selected line,
and that contribution of ErbB2 may be more important in
Tam- and β-HCH- selected cells than E2-selected ones in
terms of promoting cell proliferation. This possibility was
further checked by examining the changes in mRNA
expressions of AhR (Figure 2) and ErbB2 (Figure 3) in
these 3 sub-lines during their selection process. It is appar-
ent from this study that the expression of AhR is indeed
outstanding in E2-selected cells (Figure 2), and that the
elevated expression of ErbB2 mRNA is most pronounced
in β-HCH selected cells followed by those selected by Tam
(Figure 3). In general, those selected MCF10AT1 cells pas-
sages showed the highest expression of AhR and ErbB2
mRNAs after 20 passages, except in the case of AhR expres-
sion in Tam-selected cells, and ErbB2 expression in β-HCH
selected ones, both of which showed the sign of decline of
their expression in 20 passage from that was found in 18
passage. In view of this observation, we have decided not
to subject those cells for further selection by any of these
selecting agents beyond 20 passages in the case of
MCF10AT1.
Comparison of selected MCF10AT1 cells to similarly 
selected MCF-7 cells
Since one of the main objectives of this study was to inves-
tigate the cause for AhR overexpression in breast cancer
cells, we wanted to have at least another example of mam-
mary epithelial cells developing AhR overexpression for
the purpose of confirming the effect of E2. Fortunately we
have already conducted a similar experiments on MCF-7Page 4 of 15
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lizing essentially identical procedures for 35 generations
[18]. At that time, however, we had no knowledge on the
expression of AhR or its consequences in those selected
MCF-7 cell lines. The results of qRT-PCR assessments of
selected marker mRNA expressions in these two E2-
selected lines of MCF10AT1 and MCF-7 (Figure 4) show
that for the given treatments, the basic mRNA expression
profile of these two different cell lines are remarkably sim-
ilar. For instance, in both cell lines, E2-selection induced
the highest level of mRNA expression of AhR followed by
those selected by 4-OH-tamoxifen (Tam) and β-HCH. A
parallel assay on CYP1A1 expression, which is being used
here as a marker for the functional activation of AhR, indi-
cated that, while E2-selected ones (i.e. P35E and P20E for
MCF-7 and MCF10AT1) still showed the highest expres-
sion among all sub-lines within each MCF cell group, β-
HCH selected cells (as compared to "mock" selected con-
trol cells) exhibit also relatively higher expressions of the
ratio of CYP1A1/AhR than Tam-selected ones. This set of
data indicated that the level of induction of AhR is not
exactly identical to that of CYP1A1, implying that the
functional activation of AhR may be governed by a differ-
ent set of cellular conditions or factors than its mRNA
induction. Nevertheless, in both cases, E2-selected cell
lines showed clearly the highest levels of AhR and CYP1A1
mRNA expressions among all selected lines. The observa-
tion that E2-selection in both MCF10AT1 and MCF-7 cell
lines resulted in AhR overexpression and an increased pro-
liferation indicates that estrogen signaling suppression
might play a dominant role in these processes. In addi-
tion, these observations indicate some growth factor sign-
aling such as that mediated by ErbB2 or their downstream
signaling cascades are also likely to play important roles as
well. As for the status of the estrogen receptor (ER), these
two E2-selected cell lines show some different characteris-
tics (Figure 4). E2-selected MCF-7 line (P35E) was found to
show a drastically low mRNA level of ERα, but E2-selected
MCF10AT1 line (i.e. P20E) did not show such a decrease in
the mRNA expression of ERα as compared to the matched
"mock"-selected control cell line (designated as P20C)
(not shown). However, P20E MCF10AT1 cells showed no
detectable level of expression of either progesterone recep-
tor (PR) as in the case of P35E (shown in Figure 4) or PS2
(not shown). Such an observation suggests that in both
cell lines ER functions are likely suppressed. The differ-
ence between these two cell lines appears to be that, in the
case of P20E it is ER signaling that is impaired, but in the
case of P35E it is the ERα mRNA titer that is suppressed.
In the case of ErbB2 mRNA, both E2-selected and 1 μM β-
HCH-selected cells in both cell lines showed high expres-
sion ErbB2 (= c-Neu or HER2). Of great interest to this
study was the differential upregulation of AhR and ErbB2
in cell lines selected by E2, 4-OH-tamoxifen and β-HCH
respectively. The differences among them might represent
different routes through which MCF10AT1 cells could be
affected by these chemicals to develop transformation. An
Cell proliferation of MCF10AT1 cells selected over 12–20 passages in the presence of 17-β-estradiol (E2), 17-β-Tamoxifen (Tam) r β-hexachlorohexane (β-HCH)Figure 1
Cell proliferation of MCF10AT1 cells selected over 12–20 passages in the presence of 17-β-estradiol (E2), 17-β-
Tamoxifen (Tam) or β-hexachlorohexane (β-HCH).Page 5 of 15
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study are: (a) E2 selection resulted in the greatest up-regu-
lation of AhR mRNA expression, (b) β-HCH, on the other
hand, greatly increases mostly ErbB2 mRNA expression,
and (c) 4-OH-tamoxifen produces an intermediate type of
cells showing modest increases in the expression of both
of these markers. These findings support our notion that
AhR overexpression is a likely result of alteration of the
status of the estrogen receptor as a result of exposure to
excess E2 or to 4-OH-tamoxifen.
Effects of chemical and siRNA suppressors of the function 
of AhR, and ErbB2 on proliferation of P20E cells in 
comparison to P20C cells
To investigate the possibility that AhR may be a contribut-
ing factor for increased cell proliferation in this trans-
formed mammary epithelial cell type, we re-examined the
influence of several diagnostic inhibitory agents on P20E
and P20C cells. The results summarized in Table 2 show
that MNF, an AhR antagonist, is indeed a powerful agent
suppressing the rate of cell proliferation in P20E cells both
in the presence and the absence of exogenous heregulin
(HRG). In addition, the anti-inflammatory agent parthe-
nolide was also quite effective in suppressing prolifera-
tion. Resveratrol, which has both AhR antagonist [19,20]
and anti-inflammatory properties [21], was the most
effective in proliferation suppression particularly in P20E
cells. To confirm the role of AhR on cell proliferation fur-
ther, we have tested the effectiveness of two siRNA prepa-
rations (Table 3), i.e. siAhR and si-β-catenin and
compared them to neg-siRNA (Qiagen -"Allstar"). The si-
β-catenin was used as a positive control to suppress cell
proliferation that are mediated by this wnt/β-catenine
pathway, which might or might not include the one medi-
ated by AhR. The results showed that, while both siRNA
preparations were effective in suppressing proliferation of
both cell lines, siAhR appears to be more effective in
equalizing the rate of proliferation between these two
lines of cells in culture.
AhR expression in MCF10AT1 cells selected for various passages in the presence of 17-β-estradiol (E2), 4-OH-Tamoxifen (Tam) or β-hexachlorohexane (bHCH)Figure 2
AhR expression in MCF10AT1 cells selected for various passages in the presence of 17-β-estradiol (E2), 4-OH-
Tamoxifen (Tam) or β-hexachlorohexane (bHCH).Page 6 of 15
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resistance to induced apoptosis in P20E cells compared to 
P20C cells
To assess the contribution of AhR in conferring P20E cells
another typical phenotype of transformation, we have
selected apoptosis resistance. In the first series of experi-
ments apoptotic stimuli were provided by externally
applied ultraviolet (UV)-irradiation on cells maintained
under a modestly serum-deprived culture conditions (i.e.
24 hrs serum deprivation) (Figure 5). This UV-treatment
induced approximately 5-fold increase in apoptosis under
our test conditions in P20C, but only 2.5-fold increase in
P20E. TCDD treatment induced an anti-apoptotic reaction
as shown previously [22], but mostly on P20C only. All
suppressors of AhR consistently induced marked increases
of apoptosis. Resveratrol, which is known to have both
agonistic and antagonistic action on AhR, on the other
hand, acted like TCDD in this case suppressing apoptosis
in both cell lines. To test the possibility that this contribu-
tion of AhR confers apoptosis resistance to more than one
ErbB2 expression in MCF10AT1 cells selected for various passages in the presence of 17-β-estradiol (E2), 4-OH-Tamoxifen (Tam) or β-hexachlorohexane (bHCH)Figure 3
ErbB2 expression in MCF10AT1 cells selected for various passages in the presence of 17-β-estradiol (E2), 4-
OH-Tamoxifen (Tam) or β-hexachlorohexane (bHCH).
Table 1: Effects of inhibitors on the cell proliferation of MCF10AT1 sub-lines selected in the presence of 17-β-estradiol (E2), Tam and β-
Hexachlorohexane (β-HCH) *p < 0.05 vs. control ap < 0.05 vs. no chemicals.
Control E2 Tam β-HCH
Time 0 100 ± 6.8 100 ± 5.0 100 ± 12.1 100 ± 11.9
After 48 hours:
No chemicals 787 ± 65 1274 ± 61* 1456 ± 56.9* 1378 ± 138*
AG879 263 ± 16 1025 ± 51* 283 ± 13.a 535 ± 12* a
MNF 810 ± 60 850 ± 4.3a 1355 ± 52.2* 1425 ± 125*Page 7 of 15
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mRNA expression of selected proteins in long-term selected cells – MCF10AT1 and MCF-7 cell lines grown in the presence of 17-β-estradiol (E2, 1 nM), 4-OH-Tamoxifen (Tam, 10 nM) and β hexachlorohexane (β-HCH, 1 μM) fo  20 and 34 as ages respectivelyFigure 4
mRNA expression of selected proteins in long-term selected cells – MCF10AT1 and MCF-7 cell lines grown in 
the presence of 17-β-estradiol (E2, 1 nM), 4-OH-Tamoxifen (Tam, 10 nM) and β hexachlorohexane (β-HCH, 1 
μM) for 20 and 34 passages respectively. PR = progesterone receptor. * p < 0.05 ** p < 0.01 ***p < 0.001 vs control
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H2O2, staurosporin and TGFβ1 on both cell lines either in
the presence or the absence of MNF (to suppress the func-
tion of AhR) (Figure 6). Each of apoptosis inducer caused
the increase in the number of cells showing apoptosis as
expected, but their actions were invariably less pro-
nounced in P20E cells than in P20C cells. Again the effect
of MNF was to further increase the number cells showing
apoptosis, and in its presence the difference between P20C
and P20E cells disappeared.
Tests on the AhR-dependency of expression of selected 
mRNA markers
At this stage we have decided to investigate the contribu-
tions of the overexpressed AhR on the expression of sev-
eral diagnostic markers under both fresh serum (3 hrs
after the medium change with fresh serum) and serum
starved (72 hrs after the last medium change with serum).
For this purpose we conducted additional qRT-PCR stud-
ies on the expression of selected mRNA markers in P20E
and P20C cells both in the presence and the absence of
MNF to gain insight to the differential contribution of
AhR in expressing each of these marker expressions
between these two cell lines. The results (Table 4) showed
that unexpectedly CYP1A1 expression was much higher in
both cell lines under serum starved conditions than fresh
serum conditions. On the other hand, as expected its
expression was higher in P20C cells than in AhR overex-
pressing P20E, which was more apparent under serum
starved conditions. MNF, a blocker of AhR was effective in
significantly suppressing the expression of CYP1A1, indi-
cating the functional activation of AhR even in the
absence of TCDD or any other exogenous ligands. The
expression of AhR mRNA itself, on the other hand, was
not drastically affected by the culture conditions of those
cells or by MNF. In comparison, both ErbB2 and TGF-β1
showed a higher levels of expression under serum starved
conditions than in fresh serum conditions as in the case of
CYP1A1, except that their sensibility to MNF was apparent
only in P20E cells. In contrast TGF-α and heregulin (HRG)
expression was higher under fresh serum conditions than
in serum starved conditions. On the other hand, the
effects of serum or MNF on PI3K were not significant. This
set of experiments established that the contributions of
AhR to the expression of those selected markers are greatly
affected by the condition of serum in culture medium. It
appears at the same time, there are at least 2 different types
of types of markers: (a) those expression is higher under
fresh serum conditions (e.g. TGF-α and HRG), and (b)
those favor serum starved conditions (CYP1A1 and
TGFβ1). The AhR dependency of those mRNA expres-
sions, as judged by the blocking action of MNF, is mostly
confined to P20E compared to P20C (except in the case of
CYP1A1 and AhR under serum starved conditions), and is
more noticeable under the condition where the given
mRNA expression is high (e.g. HRG and TGFα under fresh
serum, and TGF-β3, ErbB2 and, to a lesser extent, ErbB2
under serum starved conditions) than the conditions pro-
moting low expression.
Studies on the influence of the overexpressed AhR on the 
mRNA expression of selected inflammation markers in 
P20E cells as compared to P20C cells
One of the characteristic functions of AhR is to mediate
the action of dioxin to induce cellular inflammatory
responses [23]. Preliminary test results showed that the
expressions of inflammation markers are higher under
fresh serum conditions than starved ones. Accordingly in
this sub-project we have tested the possibility of the over-
expressed AhR affecting the inflammatory status of P20E
cells under fresh serum conditions only. The results sum-
marized in Table 5 indicate that markers that are differen-
tially affected by MNF in these two cell lines are COX-2,
CSF-1, and MCP-1. In addition, the markers affected by
MNF only in P20E cells were NOX-2 (NADPH oxidase 2),
and NFkB. Two anti-inflammatory agents, NS389 (a COX-
2 inhibitor) and quercetin (a bioflavonoid with overall
anti-inflammatory/anti-oxidant activities) were used to
assess the extent of their participation in causing the cellu-
lar state of inflammation. The result showed that, as
expected, these two agents are reasonably effective in sup-
pressing the expression of NFκB. In addition, they gener-
ally reduced the expression of other markers to roughly
the similar extents as those achieved by MNF. These find-
ings support the rationale of selecting these mRNAs as the
Table 2: Proliferation in MCF10AT1 cell sublines selected over 20 
passages in 17-β-Estradiol (P20E2) or the ethanol vehicle (P20C).
Cell lines: P20C P20E
Control 100 ± 10 224 ± 11
+ Resveratrol (20 μM) 91 ± 15 123 ± 12*;
+ Parthenolide (10 μM) 98 ± 15 183 ± 8.5*
+ MNF (10 nM) 103 ± 6.3 178 ± 8.8*
+ HRG (1 ng/ml) 108 ± 8.0 295 ± 12a
+ HRG + MNF 108 ± 7.4 184 ± 9.2
Cells were measured 72 hrs after plating. * p < 0.05 inhibitors vs. 
control, a p < 0.05 HRG vs. control, b <0.05 HRG+MNF vs. HRG
Table 3: Effect of AhR and β-Catennin siRNA on proliferation in 
MCF10AT1 cell sub-lines selected over 20 passages in 17-β-
Estradiol (p20 E2) or the ethanol vehicle (p20 C).
Cell lines: P20C P20E
Control neg-siRNA 100 ± 6.3 195 ± 10.1* a
β-Catenin siRNA 60 ± 4.2a 103 ± 12.5* a
AhR siRNA 63 ± 4.2a 86 ± 8.7* a
Cells were measured 72 hours after plating. * p < 0.05 HRG vs. 
control, (a)p < 0.05 control vs. siRNAPage 9 of 15
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BMC Cancer 2009, 9:234 http://www.biomedcentral.com/1471-2407/9/234markers for inflammation. They also indicated that the
expression of these markers are definitely higher in P20E
than in P20C, and that, judging by the suppressive effect of
MNF, AhR contributes to their increase expression to cer-
tain extent.
Electromobility Shift Assay (EMSA) study on AhR binding 
to the dioxin response element (DRE) in P20E in 
comparisons to P20C cells
To ascertain the functional importance of the overex-
pressed AhR on the increased expression of CYP1A1(pre-
viously illustrated in Figure 4 top left), which is known to
be activated by AhR:ARNT dimmer binding to dioxin
response element (=DRE), an EMSA analysis was con-
ducted on nuclear proteins isolated from samples of P20C
and P20E cells under fresh serum (6 hrs after medium
change with fresh serum) and serum starved (72 hrs after
the last serum change/24 hours since last media change)
conditions. In addition, as a positive control, the effect of
TCDD (10 nM) was also determined under these condi-
tions to confirm the presence of the AhR:ARNT-DRE com-
plex. The results in Figure 7A have revealed that nuclear
protein binding to the DRE sequence of oligonucleotides
is clearly higher in the samples obtained from the overex-
pressed AhR in P20E cells than those prepared from
"mock-selected" P20C cells. This observation indicates
that these DRE binding proteins (likely including AhR)
are functionally active in terms of their DRE binding even
without the presence of the exogenously added ligand
under this test condition. Thus, in this system, overex-
pressed AhR confers P20E cells the additional influence of
functionally active AhR over that is found in P20C. Inter-
estingly the effect of TCDD appears to be more pronounce
in cells under serum starved conditions, while the extent
Differential effects of apopototic action of UV-irradiation between P20C and P20E cells, and the influence of AhR affecting, diag-nostic agents in synergizing or antagonizing the effect of UV-irradiationFigu  5
Differential effects of apopototic action of UV-irradiation between P20C and P20E cells, and the influence of 
AhR affecting, diagnostic agents in synergizing or antagonizing the effect of UV-irradiation. ** the difference 
between P20C and P20E was significant at p < 0.01. b the effect of MNF, AG879, Resveratrol (Resv) or pAhRR, as compared to 
UV alone, was significant at p < 0.001.Page 10 of 15
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Differential effects of apoptosis-inducing action of hydrogen peroxide (H2O2), staurosporin and TGFβ1 and their dependency on the function of AhRFigu  6
Differential effects of apoptosis-inducing action of hydrogen peroxide (H2O2), staurosporin and TGFβ1 and 
their dependency on the function of AhR. *,**,*** the difference between P20C and P20E was significant at p < 0.05, 0.01 
or 0.001, respectively. a, aa, aaaThe effect of each treatment, as compared to "None", was significant at p < 0.05, 0.01 or 0.001, 
respectively.
Table 4: Effect of serum starvation of P20C and P20E cells on the expression of selected marker mRNAs.
Fresh serum Serum starvation
mRNA P20C P20E P20C P20E
C MNF C MNF C MNF C MNF
CYP1A1 1.00 1.25 1.21 1.03 28.38**bb 10.18**abb 41.16**bb 25.36**abb
AhR 1.00 1.03 2.11* 1.74* 2.02**bb 1.46**bb 1.43** 1.67*
ErbB2 1.00 1.68*a 4.24** 2.07*a 4.24**bb 5.81**bb 5.41***bb 3.21*ab
HRG 1.00 1.84*a 11.82** 3.47*a 0.82 0.93b 0.51**bb 0.24**ab
PI3K 1.00 1.00 2.67* 2.64** 1.51**bb 1.90*b 3.72**bb 4.27***bb
TGF-α 1.00 1.10 1.49 1.18 0.98 0.80bb 0.23**bb 0.28**bb
TGF-β3 1.00 2.04**a 4.96*** 2.87*a 7.03*b 7.65**bb 12.61**bb 8.41**ab
Statistical symbols are: * different from control (C = 1.00) fresh serum P20C, a significant effect of MNF from the matched control, b significant effect 
of serum starvation. One symbol indicates P ≤ 0.05; two P ≤ 0.01; three P ≤ 0.001.
Serum/medium was given 3 hrs prior to the test designated as "fresh medium." For "serum starvation" tests, the same batch of cells treated with 
fresh serum/medium were given serum-free medium after 48 hrs and the samples were harvested 24 hrs thereafter.
BMC Cancer 2009, 9:234 http://www.biomedcentral.com/1471-2407/9/234of protein binding to the DRE sequence in the absence of
TCDD is actually higher in serum fresh conditions than
starved conditions. This finding suggests that under fresh
serum conditions the level of constitutively activated AhR
function in P20E, even in the absence of exogenously
added ligands, is already very high (i.e. higher than that is
found in P20C exposed to 10 nM of TCDD). To test the
specificity of AhR functionality, gel-shift (i.e. supershift)
assays were performed onP20C and P20E cells under fresh
serum conditions (Figure 7B). Recent studies in our labo-
ratory have demonstrated that the NFκB subunit RelB can
crosstalk and dimerize with AhR to activated DRE [24-26]
especially in the absence of an AhR ligand. Therefore it
was not surprising that both the AhR and RelB antibody
resulted in the loss of AhR/DRE complex (Figure 7B) and
appearance of new supershift bands. The ARNT antibody
which does not affect the AhR/DRE complex under these
conditions acts as a negative-antibody control.
Western blotting studies on the protein expression of AhR 
in P20E and P20C cells
Since overexpression of AhR in P20E cells in comparison
to P20C cells has only be studied so far by its mRNA
expression and by assessing the parallel increase in
CYP1A1 mRNA expression, we conducted a western blot
test to assess the titer of its protein in these two strains of
cells. Indeed, we could confirm the higher AhR protein
expression in P20E cells than that in P20C cells (Figure 8).
Studies on the effect of AhR on the expression of ERE-
target genes through the use of ERE-Luc reporter plasmid
In view of the lack of the difference in the level of expres-
sion of ERα protein between these two cell lines, we
hypothesized that the actual difference may be in the
function of ERα itself. To test this hypothesis, we assessed
the levels of estrogen response element (ERE)-mediated
gene expression in P20E and P20C cell lines using an ERE-
Luciferase (ERE-luc) reporter plasmid transfection
approach. The result (Figure 9) clearly showed that the
level of constitutive expression of the luciferase activity is
Table 5: mRNA expression of selected inflammatory and 




C MNF C MNF NS398 Quercetin
NFκB 1.00 1.30 2.25*** 2.00 1.52a 1.45aa
MCP-1 1.00 0.80 4.07*** 3.07 2.21aa 1.01aaa
CSF-1 1.00 0.84 3.77*** 2.66***a 3.45 5.92a
COX-2 1.00 0.72 5.67*** 2.72***a 3.60aa 2.11aaa
NOX-2 1.00 1.10 3.75*** 2.49***a 3.97 2.85a
EMSA on Dioxin response element (DRE) ActivationFigure 7
EMSA on Dioxin response element (DRE) Activation. 
Nuclear proteins from P20C and P20E cells grown under 
"fresh" serum and serum starved conditions alone or in the 
presence of TCDD (10 nM-3 hrs) were hybridized with a 
DRE-containing 32-P labeled oligonucleotide.
Western blot for AhR protein expression in P20C vs P20E cellsFigure 8
Western blot for AhR protein expression in P20C vs 
P20E cells.Page 12 of 15
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more, treatment of these cells with an siRNA against AhR
(siAhR) or that against ARNT (a required dimerization
partner for the AhR target gene activation) clearly caused
up-regulation of the luciferase expression, indicating that
AhR and its dimer with ARNT work antagonistic to the
nuclear transcription factors (likely including the ER)
binding to ERE as positive regulators.
Discussion
Our main strategy for the current study has been first to
identify the most likely cause for these MCF breast cancer
cells to overexpress AhR by checking the effectiveness of
three estrogenic agents in stimulating the expression of
AhR for a number of passages, and second to identify phe-
notypic signs of transformation along the process of
selecting those cells by these agents. This approach has
yielded two major tangible results: (a) in our main study
cell lines, MCF10AT1 (i.e. P20E) as well as in MCF-7(P35E)
cells, E2 was the most effective agent, among tested in
terms of eliciting AhR overexpression, and (b) E2 selection
resulted in transformed cells with a phenotypic expression
of the increased cell proliferation in both cell lines. The
above finding suggests that the estrogen receptor (ER) is
likely involved in this process of AhR up-regulation at
least in these cell lines under our test conditions. In the
case of MCF-7 cells we found the mRNA expression of
ERα itself in E2-selected cells (P35E) is totally suppressed.
On the other hand in the case of E2-selected MCF10AT1
cells (P20E) the extent of down-regulation of expression of
ERα mRNA, in comparison to P20C cells, was not rela-
tively modest. Instead we found that the level of mRNA
expressions of progesterone receptor (PR) and PS2, both
estrogen receptor element (ERE) controlled proteins, were
very low, indicating possibly that the function of the ERα
is impaired in P20E as a result of its overexpression of AhR.
In this regard, the results of ERE-Luciferase (ERE-Luc)
assays (Figure 9) were most helpful in confirming the
above diagnosis, since both siRNA treatments aimed at
reducing the expression of AhR caused the restoration of
ERE-Luc activity in both cell lines. This indicates that there
is definitely a good possibility of the existence of an antag-
onistic influence of AhR on the expression of genes pro-
moted by ERE. Furthermore, even in the absence of
siRNA, the level of ERE-dependent gene expression in
P20C was found to be significantly higher than that in
P20E. One unexplainable question remaining is why the
extent of the effect of those siRNA treatments in recover-
ing ERE-dependent gene expression is more pronounced
in P20C than in P20E: i.e. if the degree of AhR dependency
of ERE-suppression is higher in P20E than P20C, the
expected outcome of suppression of AhR would be more
in the former. One possibility, which we consider likely to
explain this observation, is that this phenomenon is due
Differential level of expression of Estrogen Response Element (ERE)-dependent gene activation between P20C and P20E cells, and assessm nt of the effectiveness of siAh  and siArnt to i erfere the function of AhR and Arnt, respectively as determined via pERE-Luc r p rt r assays o  P20C vs. P20E cellsFigu  9
Differential level of expression of Estrogen Response Element (ERE)-dependent gene activation between P20C 
and P20E cells, and assessment of the effectiveness of siAhR and siArnt to interfere the function of AhR and 
Arnt, respectively as determined via pERE-Luc reporter assays on P20C vs. P20E cells. **,*** The effect of siAhR or 
siArnt treatment, as compared to "scrambled RNA" treated sample in each strain of cells, were significant at p < 0.01 or 0.001, 
respectively.Page 13 of 15
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mated to be effective in suppressing 70% of AhR mRNA
expression). In other words, even the remaining AhR still
expressed in P20E cells is powerful enough to keep the
expression of the ERE-target genes suppressed. An alter-
nate possibility is that there is another factor other than
AhR which makes the functional activation of ERE less
effective in P20E cells than in P20C. The third possibility,
which is even less likely, is that the transfection efficiency
of these cells with the ERE-Luc plasmid was compromised
due to molecular differences between the two sublines.
Nevertheless, the main conclusion derived from these
experiments that the functions of ERα and ERE are
reduced in P20E cells in comparison to P20C is still firm,
clearly supporting our conclusion.
The second major objective has been to find the effect of
the overexpressed AhR on the increased expression of at
least one phenotype indicating the AhR-dependent pro-
gression to more advanced state of transformation. It
must be noted that MCF-7 P35E line, in comparison to its
matched control P35C line, has already been shown to
exhibit several phenotypic characteristics of further
advanced state of transformation such as accelerated
anchorage-independent growth in soft agar, increased
invasiveness, as judged by matrigel invasion tests, and cell
proliferation [17]. These changes were accompanied with
marked suppression of expressions of ERα and significant
increase in that of MMP-9 both at protein and enzymatic
levels [17]. Since much less is known about MCF10AT1
derived P20E cells than those selected from MCF-7 (i.e.
P35E versus P35C cells), we decided to study MCF10AT1 as
our main cellular model in examining this phenomenon
of AhR overexpression in more detail. In this regard, the
most noticeable finding of the current study has been that
AhR overexpression through E2-selection is accompanied
with increased cell proliferation in both MCF cells lines.
This observation merits special attention, since increased
cell proliferation is clearly one of the major phenotypic
expressions of advanced transformation of mammary epi-
thelial cells. The most significant pieces of evidence pro-
cured for the critical contribution of AhR in helping P20E
cells to express the above transformation characteristics
were first, the effectiveness of MNF, a specific blocker of
AhR and second, that of siRNA against AhR in effectively
suppressing cell proliferation of P20E cells. Thus, by this
approach we could satisfactorily meet the second objec-
tive of this project to unequivocally show, at least in one
case, that AhR indeed contributes significantly to the pro-
gression of transformation of mammary epithelial cells.
To support the above diagnosis of the influence of AhR on
progression of cellular transformation, we have further
conducted the apoptosis resistance study, which clearly
showed that AhR overexpression is intimately associated
with the phenotypic expression of apoptosis resistance in
P20E cells.
The third topic needing discussion is the relationship
between AhR overexpression in these cells and their
inflammatory status. The extent of contribution AhR on
the expression of these inflammation markers was
assessed by the effectiveness of MNF in reducing the
mRNA expression of those markers (Table 4). However,
the extent of suppression achieved by MNF was not com-
plete in all cases. Judging by the effectiveness of partheno-
lide, an anti-inflammatory agent, in reducing the
proliferation difference between P20E and P20C, on the
other hand (Table 2), there is likely possibility that
inflammation itself is contributing to the expression of
this phenotype. Nevertheless, at this early stage of investi-
gation, the contribution of the overexpressed AhR on the
increased expression of the inflammation status in P20E
cells is still based on this circumstantial evidence only,
and therefore this subject still remains to be resolved in
the future.
One final topic needing a brief discussion is how the ele-
vated AhR in MCF cells becomes functionally activated
even without addition of exogenous ligands. It must be
pointed out that we avoided the use of typical ligands
such as TCDD throughout this study (except in Figure
7A). Yet, the result of this current study indicates unam-
biguously that overexpressed AhR in P20E cells are func-
tionally active even without exogenous ligands (e.g. see
Figure 7 and 9). Therefore, while we could not address this
specific question in this study, this topic deserves a serious
attention in the future.
Conclusion
We could clearly establish in the current study that E2-
selection causes induction of AhR overexpression in two
MCF breast cancer cell lines, and that such a phenomenon
is accompanied with increased cell proliferation that is
significantly dependent on the presence of AhR. The evi-
dence suggests that the basic cause for up-regulation of
AhR by E2-selection is related to the E2-induced down-reg-
ulation of either expression of ERα as in the case of MCF-
7 cells, or the loss of the function of estrogen responsive-
ness in MCF10AT1 cells.
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